메뉴 건너뛰기




Volumn 104, Issue 15, 2001, Pages 1863-1867

Improving coronary heart disease risk assessment in asymptomatic people: Role of traditional risk factors and noninvasive cardiovascular tests

Author keywords

Coronary disease; Prevention; Prognosis; Risk factors

Indexed keywords

CLINICAL PRACTICE; CORONARY RISK; DIAGNOSTIC TEST; HUMAN; ISCHEMIC HEART DISEASE; NON INVASIVE MEASUREMENT; PRACTICE GUIDELINE; PRIMARY PREVENTION; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; RISK FACTOR;

EID: 0035834030     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/hc4201.097189     Document Type: Review
Times cited : (472)

References (34)
  • 2
    • 0034602627 scopus 로고    scopus 로고
    • AHA Conference Proceedings: Prevention conference V: Beyond secondary prevention: Identifying the high-risk patient for primary prevention: Executive summary: American Heart Association
    • (2000) Circulation , vol.101 , pp. 111-116
    • Smith, S.C.1    Greenland, P.2    Grundy, S.M.3
  • 3
    • 0035897696 scopus 로고    scopus 로고
    • Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III)
    • (2001) JAMA , vol.285 , pp. 2486-2497
  • 4
    • 0028883828 scopus 로고
    • Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia: West of Scotland Coronary Prevention Study Group
    • (1995) N Engl J Med , vol.333 , pp. 1301-1307
    • Shepherd, J.1    Cobbe, S.M.2    Ford, I.3
  • 5
    • 0032572086 scopus 로고    scopus 로고
    • Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: Results of AFCAPS/TexCAPS: Air Force/Texas Coronary Atherosclerosis Prevention Study
    • (1998) JAMA , vol.279 , pp. 1615-1622
    • Downs, J.R.1    Clearfield, M.2    Weis, S.3
  • 6
  • 7
    • 0034688194 scopus 로고    scopus 로고
    • Effects of an angiotensin-convertingenzyme inhibitor, ramipril, on cardiovascular events in high-risk patients: The Heart Outcomes Prevention Evaluation Study Investigators
    • (2000) N Engl J Med , vol.342 , pp. 145-153
    • Yusuf, S.1    Sleight, P.2    Pogue, J.3
  • 8
    • 0033042849 scopus 로고    scopus 로고
    • Evaluating novel cardiovascular risk factors: Can we better predict heart attacks?
    • (1999) Ann Intern Med , vol.130 , pp. 933-937
    • Ridker, P.M.1
  • 11
    • 0031728287 scopus 로고    scopus 로고
    • Prevention of coronary heart disease in clinical practice: Recommendations of the Second Joint Task Force of European and other Societies on Coronary Prevention
    • (1998) Atherosclerosis , vol.140 , pp. 199-270
    • Wood, D.1    De Backer, G.2    Faergeman, O.3
  • 13
    • 0033210739 scopus 로고    scopus 로고
    • AHA/ACC scientific statement: Assessment of cardiovascular risk by use of multiple-riskfactor assessment equations: A statement for healthcare professionals from the American Heart Association and the American College of Cardiology
    • (1999) J Am Coll Cardiol , vol.34 , pp. 1348-1359
    • Grundy, S.M.1    Pasternak, R.2    Greenland, P.3
  • 15
    • 0029157354 scopus 로고
    • Identifying adults at increased risk of coronary disease: How well do the current cholesterol guidelines work?
    • (1995) JAMA , vol.274 , pp. 801-806
    • Grover, S.A.1    Coupal, L.2    Hu, X.P.3
  • 16
    • 0030713021 scopus 로고    scopus 로고
    • The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure
    • (1997) Arch Intern Med , vol.157 , pp. 2413-2446
  • 17
    • 0033485508 scopus 로고    scopus 로고
    • Low risk-factor profile and long-term cardiovascular and noncardiovascular mortality and life expectancy: Findings for 5 large cohorts of young adult and middle-aged men and women
    • (1999) JAMA , vol.282 , pp. 2012-2018
    • Stamler, J.1    Stamler, R.2    Neaton, J.D.3
  • 18
    • 0034621642 scopus 로고    scopus 로고
    • Impact of evidence-based "clinical judgment" on the number of American adults requiring lipid lowering therapy based on updated NHANES III data: National Health and Nutrition Examination Survey
    • (2000) Arch Intern Med , vol.160 , pp. 1361-1369
    • Jacobson, T.A.1    Griffiths, G.G.2    Varas, C.3
  • 19
    • 0033621070 scopus 로고    scopus 로고
    • Primary prevention of coronary heart disease: Integrating risk assessment with intervention
    • (1999) Circulation , vol.100 , pp. 988-998
    • Grundy, S.M.1
  • 21
    • 17344383811 scopus 로고    scopus 로고
    • Prevention Conference V: Beyond secondary prevention: Identifying the high-risk patient for primary prevention: Tests for silent and inducible ischemia: Writing Group II
    • (2000) Circulation , vol.101
    • Smith, S.C.1    Amsterdam, E.2    Balady, G.J.3
  • 22
    • 0034602617 scopus 로고    scopus 로고
    • Prevention Conference V: Beyond secondary prevention: Identifying the high-risk patient for primary prevention: Noninvasive tests of atherosclerotic burden: Writing Group III
    • (2000) Circulation , vol.101
    • Greenland, P.1    Abrams, J.2    Aurigemma, G.P.3
  • 24
    • 0030848434 scopus 로고    scopus 로고
    • Association of coronary heart disease incidence with carotid arterial wall thickness and major risk factors: The Atherosclerosis Risk in Communities (ARIC) Study, 1987-1993
    • (1997) Am J Epidemiol , vol.146 , pp. 483-494
    • Chambless, L.E.1    Heiss, G.2    Folsom, A.R.3
  • 33
  • 34
    • 0034654457 scopus 로고    scopus 로고
    • The cardiovascular event reduction tool (CERT): A simplified cardiac risk prediction model developed from the West of Scotland Coronary Primary Prevention Study (WOSCOPS)
    • (2000) Am J Cardiol , vol.85 , pp. 720-724
    • L'Italien, G.1    Ford, I.2    Norrie, J.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.